Megan N. Thobe

567 total citations
11 papers, 444 citations indexed

About

Megan N. Thobe is a scholar working on Molecular Biology, Pathology and Forensic Medicine and Cellular and Molecular Neuroscience. According to data from OpenAlex, Megan N. Thobe has authored 11 papers receiving a total of 444 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 3 papers in Pathology and Forensic Medicine and 3 papers in Cellular and Molecular Neuroscience. Recurrent topics in Megan N. Thobe's work include Cancer Mechanisms and Therapy (3 papers), Liver physiology and pathology (3 papers) and Axon Guidance and Neuronal Signaling (3 papers). Megan N. Thobe is often cited by papers focused on Cancer Mechanisms and Therapy (3 papers), Liver physiology and pathology (3 papers) and Axon Guidance and Neuronal Signaling (3 papers). Megan N. Thobe collaborates with scholars based in United States. Megan N. Thobe's co-authors include Susan E. Waltz, Peterson Pathrose, Mike A. Leonis, Devikala Gurusamy, E. Ellen Jones, Trisha M. Wise‐Draper, Karl Münger, Susanne I. Wells, Belinda E. Peace and Margaret H. Collins and has published in prestigious journals such as SHILAP Revista de lepidopterología, Cancer Research and Oncogene.

In The Last Decade

Megan N. Thobe

10 papers receiving 433 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Megan N. Thobe United States 7 265 154 128 122 56 11 444
Purnima K. Wagh United States 9 286 1.1× 136 0.9× 117 0.9× 103 0.8× 46 0.8× 11 449
Julien Deheuninck France 7 343 1.3× 110 0.7× 109 0.9× 47 0.4× 31 0.6× 8 455
Zongling Ji United Kingdom 12 491 1.9× 117 0.8× 110 0.9× 41 0.3× 29 0.5× 20 596
Lisa Lock Canada 5 319 1.2× 80 0.5× 77 0.6× 55 0.5× 16 0.3× 5 405
Jian‐Guo Geng United States 8 200 0.8× 91 0.6× 21 0.2× 109 0.9× 51 0.9× 16 420
M W Büchler Switzerland 6 209 0.8× 216 1.4× 88 0.7× 38 0.3× 11 0.2× 9 456
PG Natali United States 5 300 1.1× 178 1.2× 177 1.4× 70 0.6× 9 0.2× 8 530
Sameer A. Greenall Australia 13 203 0.8× 142 0.9× 44 0.3× 43 0.4× 10 0.2× 22 424
K. Jin Kim United States 6 204 0.8× 140 0.9× 132 1.0× 77 0.6× 5 0.1× 7 375
Timothy Ming-Hun Wan Hong Kong 12 296 1.1× 192 1.2× 58 0.5× 32 0.3× 21 0.4× 16 511

Countries citing papers authored by Megan N. Thobe

Since Specialization
Citations

This map shows the geographic impact of Megan N. Thobe's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Megan N. Thobe with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Megan N. Thobe more than expected).

Fields of papers citing papers by Megan N. Thobe

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Megan N. Thobe. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Megan N. Thobe. The network helps show where Megan N. Thobe may publish in the future.

Co-authorship network of co-authors of Megan N. Thobe

This figure shows the co-authorship network connecting the top 25 collaborators of Megan N. Thobe. A scholar is included among the top collaborators of Megan N. Thobe based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Megan N. Thobe. Megan N. Thobe is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Thobe, Megan N.. (2017). A Call to Action: Fixing the Judicially-Murkied Waters of 35 U.S.C. Section 101. Indiana Law Review. 50(3). 1023–1023.
2.
Yan, S. Betty, Suzane L. Um, Victoria L. Peek, et al.. (2014). Abstract 4403: Preclinical evaluation of LY2801653, an orally bioavailable small molecule oncokinase inhibitor, in cholangiocarcinoma models. Cancer Research. 74(19_Supplement). 4403–4403. 1 indexed citations
3.
Thobe, Megan N., Suzane L. Um, Victoria L. Peek, et al.. (2012). Abstract 2087: Detection of KRAS mutations in circulating tumor cells (CTCs) and in formalin-fixed, paraffin-embedded (FFPE) tissue using castPCR method. Cancer Research. 72(8_Supplement). 2087–2087. 1 indexed citations
4.
Thobe, Megan N., Jerilyn K. Gray, Devikala Gurusamy, et al.. (2011). The Ron receptor promotes prostate tumor growth in the TRAMP mouse model. Oncogene. 30(50). 4990–4998. 20 indexed citations
5.
Ritschdorff, Eric T., R. J. H. Clark, Donald J. Vander Griend, et al.. (2011). Building on the foundation of daring hypotheses: Using the MKK4 metastasis suppressor to develop models of dormancy and metastatic colonization. FEBS Letters. 585(20). 3159–3165. 6 indexed citations
6.
Thobe, Megan N., R. J. H. Clark, Russell Bainer, Sandip M. Prasad, & Carrie Rinker‐Schaeffer. (2011). From Prostate to Bone: Key Players in Prostate Cancer Bone Metastasis. SHILAP Revista de lepidopterología. 3(1). 478–493. 34 indexed citations
7.
Thobe, Megan N., Devikala Gurusamy, Peterson Pathrose, & Susan E. Waltz. (2009). The Ron receptor tyrosine kinase positively regulates angiogenic chemokine production in prostate cancer cells. Oncogene. 29(2). 214–226. 51 indexed citations
8.
Leonis, Mike A., Megan N. Thobe, & Susan E. Waltz. (2007). Ron-Receptor Tyrosine Kinase In Tumorigenesis and Metastasis. Future Oncology. 3(4). 441–448. 42 indexed citations
9.
Rabenau, Karen E., Dan Lu, Paul Balderes, et al.. (2006). Therapeutic Implications of a Human Neutralizing Antibody to the Macrophage-Stimulating Protein Receptor Tyrosine Kinase (RON), a c-MET Family Member. Cancer Research. 66(18). 9162–9170. 105 indexed citations
10.
Zinser, Glendon M., Mike A. Leonis, Peterson Pathrose, et al.. (2006). Mammary-Specific Ron Receptor Overexpression Induces Highly Metastatic Mammary Tumors Associated with β-Catenin Activation. Cancer Research. 66(24). 11967–11974. 87 indexed citations
11.
Wise‐Draper, Trisha M., et al.. (2005). The Human DEK Proto-Oncogene Is a Senescence Inhibitor and an Upregulated Target of High-Risk Human Papillomavirus E7. Journal of Virology. 79(22). 14309–14317. 97 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026